Baltimore, Maryland
Alzheimer's disease clinical trials in Baltimore, MD
12 Alzheimer's disease studies are recruiting participants at sites in Baltimore as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Baltimore at a glance
- 12 studies are recruiting at a site in Baltimore.
- By phase: Early Phase 1 (1), Phase 2 (3), Phase 3 (1), No phase (4), Observational (3). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (8), government (3), industry (1).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Baltimore
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)
- Observational
- Ages 55 to 110
- All sexes
- Sponsor
- National Institute on Aging (NIA)
- Study site
- National Institute of Aging, Clinical Research Unit
- Registry record
- NCT07099053 · updated
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
- Phase 2
- Ages 65 to 120
- All sexes
- Sponsor
- National Institute on Aging (NIA)
- Study site
- National Institute of Aging, Clinical Research Unit
- Registry record
- NCT07721467 · updated
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
- No phase
- Ages 60 to 100
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins Memory and Alzheimer's Treatment Center
- Registry record
- NCT06930560 · updated
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
- Early Phase 1
- Ages 18 to 85
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins Center for Psychedelic and Consciousness Research
- Registry record
- NCT04123314 · updated
Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins Hospital
- Registry record
- NCT05556395 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study sites
- Johns Hopkins University · University of Maryland Medical Center
- Registry record
- NCT06563895 · updated
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins School of Medicine
- Registry record
- NCT04601038 · updated
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins Hospital
- Registry record
- NCT05282550 · updated
Music Therapy for Patients With Alzheimer's Disease
- No phase
- Ages 18 to 89
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins School of Medicine
- Registry record
- NCT05151562 · updated
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
- No phase
- Ages 60 and older
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins School of Medicine
- Registry record
- NCT05795634 · updated
Vestibular Therapy in Alzheimer's Disease
- No phase
- Ages 60 and older
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins University School of Medicine
- Registry record
- NCT03799991 · updated
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- Observational
- All ages
- All sexes
- Sponsor
- Centers for Medicare and Medicaid Services/ Coverage and Analysis Group
- Study site
- Centers for Medicare and Medicaid Services
- Registry record
- NCT06058234 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Baltimore, MD on ClinicalTrials.gov.
Ask about studies near Baltimore
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections